英科医疗收盘上涨1.93%，滚动市盈率9.49倍，总市值149.92亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Yingke Medical, which has a current PE ratio of 9.49, significantly lower than the industry average of 49.84 [1][2] - As of March 31, 2025, Yingke Medical has 61,786 shareholders, an increase of 1,641 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - Yingke Medical operates as a comprehensive supplier of medical care products, with main business segments including medical protection, rehabilitation care, health therapy, and examination consumables [1] Group 2 - The latest financial results for Yingke Medical show a revenue of 2.494 billion yuan for Q1 2025, representing a year-on-year increase of 13.20%, and a net profit of 353 million yuan, up 48.08% year-on-year, with a gross margin of 24.16% [1] - In terms of market capitalization, Yingke Medical is valued at 14.992 billion yuan, ranking 31st in the medical device industry [1][2] - The industry median PE ratio is 36.59, indicating that Yingke Medical is trading at a significant discount compared to its peers [2]